HMC urges tobacco users to take 1st step towards tobacco-free life
Doha
Hamad Medical Corporation (HMC) on Saturday joined the world in observing World No Tobacco Day, held annually on May 31. HMC is committed to supporting the health and well-being of the community by providing accessible and effective tobacco cessation services. On World No Tobacco Day 2025, HMC has urged all tobacco users to take the first step towards a tobacco-free life.
Dr Ahmad Al Mulla, director of Tobacco Control Center, a WHO Collaborating Center at HMC, stated, 'World No Tobacco Day provides an important platform to highlight the dangers of tobacco use and the importance of supporting tobacco users to quit the habit.
'Tobacco use remains a significant public health concern in Qatar. While prevalence rates have seen some decline, continued efforts are crucial,' he said. 'According to the most recent figures, approximately 25 percent adults in Qatar are current tobacco users. This underscores the need for accessible and effective cessation services.'
Dr Al Mulla said it is important to note that the dangers of tobacco extend beyond traditional cigarettes and examine the harmful effects of other tobacco products including:
E-cigarettes and Vaping Devices: These electronic devices deliver nicotine, with harmful cancer-causing additives and flavourings, and are particularly popular among youth.
Heated Tobacco Products: These products heat tobacco to produce an inhalable aerosol, but are not risk-free.
Nicotine pouches: These products contain nicotine in varying amounts, flavourings and other ingredients and are placed in the mouth. They are available in a variety of flavors and are marketed as safe and of reduced harm.
Smokeless Tobacco: Products like chewing tobacco, snuff, and snus are placed in the mouth and absorbed, and can cause oral cancer and other health problems.
Waterpipe (Shisha, Hookah): Often perceived as less harmful, waterpipe smoking involves inhaling smoke through water, and carries significant health risks.
HMC's Tobacco Cessation Clinics play a vital role in supporting individuals who want to quit. The clinics offer a comprehensive range of services, including:
Individualized Counseling: Tailored support from trained specialists to address the specific needs of each person.
Medical Assessment: Evaluation of health status and any tobacco-related conditions.
Nicotine Replacement Therapy (NRT): Provision of NRT products (e.g., patches, lozenges) to manage and reduce withdrawal symptoms.
Medication Therapy: Prescription of non-nicotine medications, when appropriate, to aid in quitting.
Follow-up Support and education resources: Ongoing monitoring and encouragement to help individuals maintain their tobacco-free status.
'Quitting smoking is one of the best things a person can do for their health,' said Dr Al Mulla. 'At HMC's Tobacco Cessation Clinics, we provide evidence-based treatments and compassionate support to help people overcome their addiction and live healthier tobacco-free lives. We encourage anyone who wants to quit to reach out to us. We are here to help.'
How to Get HelpcTracking:>
Individuals seeking support to quit tobacco use can contact the HMC Tobacco Cessation Clinics through the following channels:
Phone: Call or message us on 5080 0959/4025 4981or call Nesma'ak on 16060
Primary Health Care Centers: Referrals can be made through primary health care centres.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
2 days ago
- Qatar Tribune
HMC launches Oncology Rehabilitation Framework
Tribune News Network Doha In an advancement for cancer survivorship and holistic care in the country, Hamad Medical Corporation (HMC) has launched the first of its kind Oncology Rehabilitation Framework. With rising cancer prevalence and growing survivorship rates in Qatar, this national initiative is the result of collaborative leadership between the Qatar Rehabilitation Institute (QRI) and the National Center for Cancer Care and Research (NCCCR). The comprehensive, nationally driven oncology rehabilitation framework addresses the full spectrum of physical, psychological, and social challenges patients face throughout their cancer journey. Grounded in international evidence and best practices, the framework reflects WHO Rehabilitation Interventions carefully adapted to Qatar's healthcare landscape and cultural context. Dr Hanadi Al Hamad, Deputy Chief of Rehabilitation, Geriatrics, Long Term and Home Care Services, and Lead of Rehabilitation Therapy Services at HMC emphasised the national importance of the initiative, stating: 'This launch marks a turning point for cancer care in Qatar. We are shifting the paradigm—moving beyond survival to ensuring that patients live with dignity, function, and independence. In line with the National Health Strategy 2024 - 2030, rehabilitation is now recognized as an essential part of the patient journey.' Dr Mohamed Salem Al Hassan, CEO and medical director of NCCCR, added: 'We are entering a new era of cancer services in Qatar—one that sees survivorship as a critical phase requiring multidisciplinary support. This framework establishes a structured, accessible, and compassionate model of care that supports every patient, each step of the way.' The National Oncology Rehabilitation Framework represents a step forward in advancing HMC's strategic vision for integrated, high-quality care. It is fully aligned with the priorities National Health Strategy 2024 –2030 and contributes directly to the goals of the Qatar National Vision 2030 by enhancing population health, building system sustainability, and empowering local capabilities. Globally, it reflects the principles of the WHO Rehabilitation 2030 Call for Action, promoting equitable, person-centered, and function-focused rehabilitation services as a core part of universal health coverage. With this launch, Qatar affirms its commitment to ensuring that people affected by cancer are supported not only to survive—but to live fully, regain independence, and enjoy a meaningful quality of life beyond their diagnosis. The National Oncology Rehabilitation Framework signals a future where recovery is defined not just by remission, but by restoring physical function, emotional well-being, and social reintegration—ensuring that every patient has the opportunity to thrive, not just survive.
Qatar Tribune
3 days ago
- Qatar Tribune
HMC highlights advanced diagnostics, and treatment on World Allergy Week
Tribune News Network Doha Hamad Medical Corporation's (HMC) Allergy and Clinical Immunology Division is marking World Allergy Week 2025 by highlighting the range of specialised services it provides to deliver comprehensive, patient-centred care for individuals affected by allergic and immunological conditions. The division specialises in diagnosing and treating conditions, lik asthma, allergic rhinitis, chronic urticaria, atopic dermatitis, food allergies, drug allergies, insect venom allergy, anaphylaxis, and eosinophilic esophagitis. It serves adults and children by combining expert clinical knowledge with advanced diagnostic technologies to improve patients' quality of life. 'This World Allergy Week, we want to emphasise that allergies are serious medical conditions that can impact the quality of life, but with proper diagnosis and treatment, they are highly manageable,' said Dr. Asaad Imameldin, specialist Allergy/Immunology and Internal Medicine. 'Accurate diagnosis is key to effective allergy management, and our approach combines advanced diagnostic testing with personalised treatment plans, ensuring that every patient receives care tailored to their specific allergies,' he added. The division offers a range of cutting-edge diagnostic methods, including skin prick testing, intradermal testing, patch testing, serum-specific IgE blood tests, oral food challenges, drug provocation testing, and spirometry for lung function assessment. Treatment plans are personalised to each patient's specific allergies and lifestyle, with options ranging from medication management and allergen avoidance counselling to immunotherapy and biologic therapies for severe conditions. Emergency action plans are developed for patients at risk of severe reactions, including the use of epinephrine auto-injectors and usage training. Patient education remains a cornerstone of the division's approach, with emphasis on teaching patients and families about allergy prevention and management through awareness programs, informational materials and personalized counselling. There are also educational programmes to guide patients on how to recognise symptoms early, avoid triggers and manage emergencies. Patients experiencing allergic condition symptoms or severe reactions are encouraged to seek consultation at HMC's Allergy and Clinical Immunology Division for early diagnosis and treatment that can significantly improve quality of life.
Qatar Tribune
24-06-2025
- Qatar Tribune
HMC launches Physical Medicine and Rehabilitation Residency Programme
Tribune News Network Doha Hamad Medical Corporation's (HMC) Qatar Rehabilitation Institute (QRI) has announced the official launch of a four-year Physical Medicine and Rehabilitation (PM&R) Residency Programme, a milestone initiative that marks a major leap forward in advancing Qatar's academic medicine and rehabilitation workforce development. The programme will commence in the upcoming academic year and is developed in alignment with international standards. This programme positions QRI as a regional leader in training future physiatrists with unparalleled access to cutting-edge technologies, interdisciplinary care, and structured academic mentorship. Dr Hanadi Al Hamad, deputy chief of Rehabilitation, Long-Term Care, and Geriatrics, and CEO and medical director of Qatar Rehabilitation Institute, expressed her pride: 'This is a prestigious achievement for QRI and for Qatar. Establishing the PM&R Residency Programme reflects our firm commitment to capacity building, clinical excellence, and innovation in rehabilitation. It is a key milestone in our strategy development as well as Qatar's National Health Strategy 2024-2030. Enhanced by the WHO's Rehabilitation 2030 initiative, we are not only shaping careers, we are shaping the future of rehabilitation in Qatar.' Dr Abdulla Rashid Al Naimi, deputy chief medical officer, Medical Education at HMC, emphasised the broader strategic value: 'The launch of this residency programme exemplifies how HMC is driving Qatar's transformation into a knowledge-based, healthcare-leading nation. It supports our vision of building a sustainable, highly skilled medical workforce and is a platform for empowerment, excellence, and future leadership.' The PM&R Residency Programme is the first of its kind in Qatar, offering a structured, accredited curriculum that empowers residents to grow into independent, research-driven, and globally competent specialists. Residents will gain hands-on experience in advanced rehabilitation services, including neuromodulation, GAIT analysis, virtual reality therapy, and spasticity management, all within a world-class, multidisciplinary clinical environment. Dr Fatma Jassim Al-Kuwari, acting chairperson of Physical Medicine & Rehabilitation and the driving force behind the establishment of the programme, commented: 'This programme is a turning point for Qatari medical graduates. It creates a direct and prestigious pathway to specialise in physical medicine and rehabilitation within our own health system. By investing in our future physicians, we are building a self-sufficient and resilient rehabilitation ecosystem that supports national priorities and inspires our youth to pursue excellence in this vital specialty.' This milestone also reflects Qatar's commitment to fostering innovation, research, and clinical leadership within rehabilitation medicine. By investing in advanced medical education, HMC and QRI are paving the way for long-term improvements in patient care, service delivery, and professional development across the continuum of care.
